Diving Into UV Safety Month Considerations

July is here, and with it comes an issue of Dermatology Times dedicated to UV Safety Month. As temperatures rise and time spent outdoors increases, there is no better moment to revisit what clinicians need to know about sun exposure, skin cancer risk, and emerging tools for protection.

Our cover feature examines 3 dimensions of UV-related skin health that dermatology clinicians navigate throughout the summer. Whitney Hovenic, MD, explores the surgical complexities of melanoma presenting in sensitive anatomical areas exposed through swimsuits and suntanning—regions where margins, reconstruction, and patient communication require particular care. We also take a closer look at melasma in patients with skin of color, where UV exposure intersects with hormonal triggers and a population that has historically faced gaps in both research and treatment. Rounding out the cover is a breakdown of the FDA's approval of bemotrizinol, the first new active sunscreen ingredient in the US in 20 years, and what its broad-spectrum photostability means for patient counseling and product selection.

Beyond the cover, we review key conversations from the Revolutionizing Atopic Dermatitis Conference 2026, where key opinion leaders discussed emerging therapies, biomarker data, and what a rapidly evolving treatment landscape means for patients living with moderate to severe disease and the clinicians managing their care.

In practice management, Joseph Gatti, DMSc, MPAS, MBA, PA-C, offers essential guidance on federal billing compliance, a topic with real consequences for practices navigating an increasingly scrutinized reimbursement environment. Rivkah Epstein, PA-C, discusses diagnosing without a safety net, examining the clinical and ethical weight of making decisions when resources, referrals, or definitive results are not always within reach.

As always, Dermatology Times delivers the most up-to-date clinical content, featuring innovative studies, FDA approvals, exclusive interviews, and expert perspectives. Stay informed with the latest data: Subscribe to Dermatology Times' e-newsletters and follow us on LinkedIn, Instagram, Facebook, X, and YouTube.